Mannkind (MNKD) Interest Expenses (2010 - 2026)
Mannkind (MNKD) reported Interest Expenses of $7.5 million for Q1 2026, up 60.99% year-over-year from $4.6 million in Q1 2025, and down 0.77% on a QoQ basis from $7.5 million in Q4 2025.
Mannkind (MNKD) has 17 years of Interest Expenses data on file, last reported at $7.5 million in Q1 2026.
- Quarterly Interest Expenses rose 60.99% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.7 million (up 18.52% YoY) and the FY2025 annual result came in at $13.8 million, up 15.43% from the prior year.
- Interest Expenses retreated to $7.5 million in Q1 2026 per MNKD's latest filing, from $7.5 million in the prior quarter.
- Across five years, Interest Expenses topped out at $7.5 million in Q4 2025 and bottomed at $285000.0 in Q2 2025.
- The 5-year median for Interest Expenses is $2.8 million (2022), against an average of $3.7 million.
- Peak annual rise in Interest Expenses reached 382.46% in 2025, while the deepest fall reached 95.29% in 2025.
- Tracing MNKD's Interest Expenses over 5 years: stood at $2.8 million in 2022, then declined by 4.7% to $2.7 million in 2023, then plunged by 41.65% to $1.6 million in 2024, then jumped by 382.46% to $7.5 million in 2025, then fell by 0.77% to $7.5 million in 2026.
- Per Business Quant, the three latest MNKD Interest Expenses figures stand at $7.5 million (Q1 2026), $7.5 million (Q4 2025), and $1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 7.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.48 Mn |
| Mar 31, 2026 | 7.48 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 285,000.00 |
| Jun 30, 2025 | 285,000.00 |
| Mar 31, 2025 | 4.65 Mn |
| Mar 31, 2025 | 4.65 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 2.68 Mn |
| Dec 31, 2023 | 2.68 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Jun 30, 2023 | 6.87 Mn |
| Jun 30, 2023 | 6.87 Mn |
| Mar 31, 2023 | 2.79 Mn |
| Mar 31, 2023 | 2.79 Mn |
| Dec 31, 2022 | 2.81 Mn |
| Dec 31, 2022 | 2.81 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Jun 30, 2022 | 6.64 Mn |
| Jun 30, 2022 | 6.64 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Sep 30, 2021 | 2.80 Mn |
| Sep 30, 2021 | 2.80 Mn |
| Jun 30, 2021 | 3.18 Mn |
| Jun 30, 2021 | 3.18 Mn |
| Mar 31, 2021 | 6.45 Mn |
| Mar 31, 2021 | 6.45 Mn |
| Dec 31, 2020 | 6.26 Mn |
| Dec 31, 2020 | 6.26 Mn |
| Sep 30, 2020 | 1.06 Mn |
| Sep 30, 2020 | 1.06 Mn |
| Jun 30, 2020 | 1.08 Mn |
| Jun 30, 2020 | 1.08 Mn |
| Mar 31, 2020 | 1.07 Mn |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | 1.02 Mn |
| Dec 31, 2019 | 1.02 Mn |
| Sep 30, 2019 | 4.13 Mn |
| Sep 30, 2019 | 4.13 Mn |
| Jun 30, 2019 | 564,000.00 |
| Jun 30, 2019 | 564,000.00 |
| Mar 31, 2019 | 593,000.00 |
| Mar 31, 2019 | 593,000.00 |
| Dec 31, 2018 | 620,000.00 |
| Dec 31, 2018 | 620,000.00 |
| Sep 30, 2018 | 993,000.00 |
| Sep 30, 2018 | 993,000.00 |
| Jun 30, 2018 | 1.71 Mn |
| Jun 30, 2018 | 1.71 Mn |
| Mar 31, 2018 | 1.79 Mn |
| Mar 31, 2018 | 1.79 Mn |
| Dec 31, 2017 | 2.06 Mn |
| Dec 31, 2017 | 2.06 Mn |
| Sep 30, 2017 | 2.31 Mn |
| Sep 30, 2017 | 2.31 Mn |
| Jun 30, 2017 | 2.42 Mn |
| Jun 30, 2017 | 2.42 Mn |
| Mar 31, 2017 | 2.71 Mn |
| Mar 31, 2017 | 2.71 Mn |
| Dec 31, 2016 | 3.01 Mn |
| Dec 31, 2016 | 3.01 Mn |
| Sep 30, 2016 | 4.17 Mn |
| Sep 30, 2016 | 4.17 Mn |
| Jun 30, 2016 | 4.18 Mn |
| Jun 30, 2016 | 4.18 Mn |
| Mar 31, 2016 | 4.22 Mn |
| Mar 31, 2016 | 4.22 Mn |
| Dec 31, 2015 | 3.33 Mn |
| Dec 31, 2015 | 3.33 Mn |
| Sep 30, 2015 | 4.15 Mn |
| Sep 30, 2015 | 4.15 Mn |
| Jun 30, 2015 | 4.13 Mn |
| Jun 30, 2015 | 4.13 Mn |
| Mar 31, 2015 | 5.80 Mn |
| Mar 31, 2015 | 5.80 Mn |
| Dec 31, 2014 | 5.65 Mn |
| Dec 31, 2014 | 5.65 Mn |
| Sep 30, 2014 | 5.42 Mn |
| Sep 30, 2014 | 5.42 Mn |
| Jun 30, 2014 | 2.43 Mn |
| Jun 30, 2014 | 2.43 Mn |
| Mar 31, 2014 | 4.04 Mn |
| Mar 31, 2014 | 4.04 Mn |
| Dec 31, 2013 | 11.45 Mn |
| Dec 31, 2013 | 11.45 Mn |
| Sep 30, 2013 | 4.32 Mn |
| Sep 30, 2013 | 4.32 Mn |
| Jun 30, 2013 | 2.87 Mn |
| Jun 30, 2013 | 2.87 Mn |
| Mar 31, 2013 | 2.86 Mn |
| Mar 31, 2013 | 2.86 Mn |
| Dec 31, 2012 | 13.32 Mn |
| Dec 31, 2012 | 13.32 Mn |
| Sep 30, 2012 | 2.86 Mn |
| Sep 30, 2012 | 2.86 Mn |
| Jun 30, 2012 | 2.84 Mn |
| Jun 30, 2012 | 2.84 Mn |
| Mar 31, 2012 | 2.58 Mn |
| Mar 31, 2012 | 2.58 Mn |
| Dec 31, 2011 | 2.85 Mn |
| Dec 31, 2011 | 2.85 Mn |
| Sep 30, 2011 | 2.85 Mn |
| Sep 30, 2011 | 2.85 Mn |
| Jun 30, 2011 | 2.83 Mn |
| Jun 30, 2011 | 2.83 Mn |
| Mar 31, 2011 | 2.41 Mn |
| Mar 31, 2011 | 2.41 Mn |
| Dec 31, 2010 | 2.83 Mn |
| Dec 31, 2010 | 2.83 Mn |
| Sep 30, 2010 | 1.88 Mn |
| Sep 30, 2010 | 1.88 Mn |
| Jun 30, 2010 | 1.21 Mn |
| Jun 30, 2010 | 1.21 Mn |